Bruker's Q3 Revenues Climb 17 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today said revenues for the third quarter jumped 17 percent year over year as the division containing its life science instruments spiked 15 percent.

For the quarter ended Sept. 30, the company posted $310.2 million in revenues, up from $265.1 million a year ago, and surpassing analyst estimates of $293.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.